CVE-2026-8310: Webbeyaz Web Design Mediküm Web · Cross-site Scripting
Affects Webbeyaz Web Design Mediküm WebSource CVE Database V5
Not known to be exploited · CVSS 6.1 Medium.
Data as of 20 Nov 2026, 17:35 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 17% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 8 Jul 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Webbeyaz Web DesignMediküm Web | Affected
| Fixed in– |
AI-suggested
No official patches or fixes are available as the product is no longer supported by the vendor. Users should consider discontinuing use of Mediküm Web or implementing web application firewall (WAF) rules to detect and block reflected XSS payloads. Additionally, applying input validation and output encoding at the application level, if possible, may reduce risk. Monitor for any unofficial patches or community mitigations.
Description
Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Webbeyaz Web Design Mediküm Web allows Reflected XSS. This issue affects Mediküm Web: through 08072026. NOTE: The vendor was contacted and it was learned that the product is not supported.